Anti-Inflammatory Activity of Crude Saponin Extracts from Five Nigerian Medicinal Plants

Crude saponin extracts of five medicinal plants used in the treatment of inflammatory diseases like rheumatoid arthritis, gout and haemorrhoids were screened for anti-inflammatory activity using carrageenan-induced rat paw oedema test. These plants were the whole plant of Schwenkia americana Linn (WSA), the rhizomes of Asparagus africanus Lam (RAA), the leaves of Dichrostachys cinerea Linn (LDC), the stem bark of Ficus iteophylla Miq (BFI) and the leaves of Indigofera pulchra Willd (LIP). A modify traditional method of crude saponins extraction was used to give the following percentage yields: WSA-2.74%, RAA-3.59%, LDC-1.62%, BFI-0.81% and LIP-1.57% respectively. Thin-layer chromatography was used to identify the type of saponins present in the extracts. The acute toxicity study of the crude saponin extracts in mice gave the following intraperitoneal LD50: WSA-471.2mg/kg, RAA- 1264.9mg/kg, LDC-1264.9mg/kg, BFI-118.3mg/kg and LIP-1264.9mg/kg respectively.  The antiinflammatory study of the extracts showed statistically significant (P<0.05) decreases in the rat paw-oedema as compared to the control. The percentage inhibitions of the extracts after four hours were as follow: WSA-61%, RAA-55%, LDC-72%, BFI-66% and LIP-40% respectively. These values were found to be comparable to that of ketoprofen-63%. The study showed that the antiinflammatory properties attributable to these plants may be due to their saponins contents.Keywords: - Asparagus africanus, Dichrostachys cinerea, Ficus iteophylla, Indigofera pulchra, Schwenkia americana, Saponin,Anti-inflammatory activity, Carrageenan, TLC

Pharmacognostic investigation of the leaves of Gisekia pharnacioides

Pharacognostic investigation of the fresh, powdered and anatomical sections of the leaves of Gisekia pharnacioides Linn was carried out to determine its macro- and microscopical characters and also some of its physical constants. Externally, the leaves possess a symmetrical base, an entire margin,obtuse apex and a pilose surface. Internally, its shows the presences of an anisocytic stomata, unicellular, uniseriated-covering trichomes with swollen base and an acute apex, prism and clustered crystals of calcium oxalate and fiber elements. The chemo-microscopy revealed the presences of lignin,mucilage, proteins, starch grains, fats and oils. Phytochemical studies of the powdered leaves revealed the presences of tannins, alkaloids, resins, cardiac glycosides, flavoniods and some carbohydrates. The results of the study could be useful in setting some diagnostic indices for the identification and preparation of a monograph of the plan

Comparative analgesic activity of the root bark, stem bark, leaves, fruits and seeds of Carissa edulis VAHL (Apocynaceae)

The analgesic activity of the water extracts (50,100 and150 mg/Kg body weight) of the root bark, stem bark, leaves, fruits and seeds of Carissa edulis were evaluated in mice using the mechanical method(tail-chip method) and chemical method (acetic acid induced writhing). The plant was found to have analgesic activity, with the fruits having the highest activity, followed by the leaves, seeds, root barkand stem bark respectively using metamizol as standard with mechanical method. There was slight variation with chemical method, the seeds were found to be most effective followed by fruits, leaves, root bark and stem bark respectively using acetylsalicylic acid as standard. The analgesic activity compared well with metamizol and aspirin which were used as standard, the chromatographic analysis indicate the presences of salicylates. These result justified the use of the plant in the treatment of toothache, lumbago, oedema and chest complaints by the traditional medical practitioners

Antisecretory and antiulcerative effects of ethyl acetate fraction of Nigella sativa (L.) Seed extract in rats

The present work was carried out to investigate the possible effects of ethyl acetate seed fraction of Nigella sativa on gastric ulcers and basal gastric secretions using the Non-Steroidal Anti-inflammatory Drug-induced (NSAID) model. Phytochemical screening according to Trease and Evans, 2002 and acute toxicity tests using the Lorke’s Method, 1983 were conducted. For the mucosal integrity study, ulcer and preventive indices were analysed, while volume of gastric juice, titratable acidity, acid output and pepsin concentration were assessed for basal gastric secretion parameters. Phytochemical screening revealed the presence of flavonoids, alkaloids, saponins, glucocinolates amongst others, while the acute toxicity studies revealed a median lethal dose above 5000mg/kg. The rats were grouped into 9 (n = 5), with the extract fraction administered at 50, 100 and 200mg/kg subcutaneously, followed by pyloric ligation with cimetidine used as the standard drug. Five rats received normal saline 1ml/kg/rat subcutaneously (S.C) as Negative Control, Five rats received indomethacin (20 mg/kg S.C), Ten rats for the study of the effect of two different doses of cimetidine 50 and 100 mg/kg S.C (5 rats for each dose). Ten rats for the study of effect of two different doses of cimetidine (50 mg and 100 mg/kg) S.C, given 30 minutes prior to indomethacin administration (5 rats for each dose). The three experimental doses of the extract at 50,100 and 200mg/kg showed a dosedependent decrease in both ulcer and preventive indices with the 200mg/kg dose at 0.6mm and 94% respectively. It also showed a significant (p<0.05) decrease in volume of gastric juice, titratable acidity, acid output and pepsin concentration in dose-dependent manner with the three experimental doses administered with the highest reduction at the 200mg/kg dose. The results obtained suggest that this fraction down-regulated all those parameters which might be attributed to the presence of the phytoconstituents present in this fraction, particularly the flavonoids. Therefore, the extract fraction of this plant possesses gastroprotective activity further explaining the folkloric use of this plant in the therapy of peptic ulcer disease.Keywords: Antiulcerative, Antisecretory, Nigella sativa, Phytochemicals, Rats, Seed Extracts

Laparoscopy in management of appendicitis in high-, middle-, and low-income countries: a multicenter, prospective, cohort study.

BACKGROUND: Appendicitis is the most common abdominal surgical emergency worldwide. Differences between high- and low-income settings in the availability of laparoscopic appendectomy, alternative management choices, and outcomes are poorly described. The aim was to identify variation in surgical management and outcomes of appendicitis within low-, middle-, and high-Human Development Index (HDI) countries worldwide. METHODS: This is a multicenter, international prospective cohort study. Consecutive sampling of patients undergoing emergency appendectomy over 6 months was conducted. Follow-up lasted 30 days. RESULTS: 4546 patients from 52 countries underwent appendectomy (2499 high-, 1540 middle-, and 507 low-HDI groups). Surgical site infection (SSI) rates were higher in low-HDI (OR 2.57, 95% CI 1.33-4.99, p = 0.005) but not middle-HDI countries (OR 1.38, 95% CI 0.76-2.52, p = 0.291), compared with high-HDI countries after adjustment. A laparoscopic approach was common in high-HDI countries (1693/2499, 67.7%), but infrequent in low-HDI (41/507, 8.1%) and middle-HDI (132/1540, 8.6%) groups. After accounting for case-mix, laparoscopy was still associated with fewer overall complications (OR 0.55, 95% CI 0.42-0.71, p < 0.001) and SSIs (OR 0.22, 95% CI 0.14-0.33, p < 0.001). In propensity-score matched groups within low-/middle-HDI countries, laparoscopy was still associated with fewer overall complications (OR 0.23 95% CI 0.11-0.44) and SSI (OR 0.21 95% CI 0.09-0.45). CONCLUSION: A laparoscopic approach is associated with better outcomes and availability appears to differ by country HDI. Despite the profound clinical, operational, and financial barriers to its widespread introduction, laparoscopy could significantly improve outcomes for patients in low-resource environments. TRIAL REGISTRATION: NCT02179112

Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy

Background The World Health Organization (WHO) Surgical Safety Checklist has fostered safe practice for 10 years, yet its place in emergency surgery has not been assessed on a global scale. The aim of this study was to evaluate reported checklist use in emergency settings and examine the relationship with perioperative mortality in patients who had emergency laparotomy. Methods In two multinational cohort studies, adults undergoing emergency laparotomy were compared with those having elective gastrointestinal surgery. Relationships between reported checklist use and mortality were determined using multivariable logistic regression and bootstrapped simulation. Results Of 12 296 patients included from 76 countries, 4843 underwent emergency laparotomy. After adjusting for patient and disease factors, checklist use before emergency laparotomy was more common in countries with a high Human Development Index (HDI) (2455 of 2741, 89.6 per cent) compared with that in countries with a middle (753 of 1242, 60.6 per cent; odds ratio (OR) 0.17, 95 per cent c.i. 0.14 to 0.21, P <0001) or low (363 of 860, 422 per cent; OR 008, 007 to 010, P <0.001) HDI. Checklist use was less common in elective surgery than for emergency laparotomy in high-HDI countries (risk difference -94 (95 per cent c.i. -11.9 to -6.9) per cent; P <0001), but the relationship was reversed in low-HDI countries (+121 (+7.0 to +173) per cent; P <0001). In multivariable models, checklist use was associated with a lower 30-day perioperative mortality (OR 0.60, 0.50 to 073; P <0.001). The greatest absolute benefit was seen for emergency surgery in low- and middle-HDI countries. Conclusion Checklist use in emergency laparotomy was associated with a significantly lower perioperative mortality rate. Checklist use in low-HDI countries was half that in high-HDI countries.Peer reviewe

The ALICE experiment at the CERN LHC

ALICE (A Large Ion Collider Experiment) is a general-purpose, heavy-ion detector at the CERN LHC which focuses on QCD, the strong-interaction sector of the Standard Model. It is designed to address the physics of strongly interacting matter and the quark-gluon plasma at extreme values of energy density and temperature in nucleus-nucleus collisions. Besides running with Pb ions, the physics programme includes collisions with lighter ions, lower energy running and dedicated proton-nucleus runs. ALICE will also take data with proton beams at the top LHC energy to collect reference data for the heavy-ion programme and to address several QCD topics for which ALICE is complementary to the other LHC detectors. The ALICE detector has been built by a collaboration including currently over 1000 physicists and engineers from 105 Institutes in 30 countries. Its overall dimensions are 161626 m3 with a total weight of approximately 10 000 t. The experiment consists of 18 different detector systems each with its own specific technology choice and design constraints, driven both by the physics requirements and the experimental conditions expected at LHC. The most stringent design constraint is to cope with the extreme particle multiplicity anticipated in central Pb-Pb collisions. The different subsystems were optimized to provide high-momentum resolution as well as excellent Particle Identification (PID) over a broad range in momentum, up to the highest multiplicities predicted for LHC. This will allow for comprehensive studies of hadrons, electrons, muons, and photons produced in the collision of heavy nuclei. Most detector systems are scheduled to be installed and ready for data taking by mid-2008 when the LHC is scheduled to start operation, with the exception of parts of the Photon Spectrometer (PHOS), Transition Radiation Detector (TRD) and Electro Magnetic Calorimeter (EMCal). These detectors will be completed for the high-luminosity ion run expected in 2010. This paper describes in detail the detector components as installed for the first data taking in the summer of 2008

Global variation in anastomosis and end colostomy formation following left-sided colorectal resection

Background End colostomy rates following colorectal resection vary across institutions in high-income settings, being influenced by patient, disease, surgeon and system factors. This study aimed to assess global variation in end colostomy rates after left-sided colorectal resection. Methods This study comprised an analysis of GlobalSurg-1 and -2 international, prospective, observational cohort studies (2014, 2016), including consecutive adult patients undergoing elective or emergency left-sided colorectal resection within discrete 2-week windows. Countries were grouped into high-, middle- and low-income tertiles according to the United Nations Human Development Index (HDI). Factors associated with colostomy formation versus primary anastomosis were explored using a multilevel, multivariable logistic regression model. Results In total, 1635 patients from 242 hospitals in 57 countries undergoing left-sided colorectal resection were included: 113 (6·9 per cent) from low-HDI, 254 (15·5 per cent) from middle-HDI and 1268 (77·6 per cent) from high-HDI countries. There was a higher proportion of patients with perforated disease (57·5, 40·9 and 35·4 per cent; P < 0·001) and subsequent use of end colostomy (52·2, 24·8 and 18·9 per cent; P < 0·001) in low- compared with middle- and high-HDI settings. The association with colostomy use in low-HDI settings persisted (odds ratio (OR) 3·20, 95 per cent c.i. 1·35 to 7·57; P = 0·008) after risk adjustment for malignant disease (OR 2·34, 1·65 to 3·32; P < 0·001), emergency surgery (OR 4·08, 2·73 to 6·10; P < 0·001), time to operation at least 48 h (OR 1·99, 1·28 to 3·09; P = 0·002) and disease perforation (OR 4·00, 2·81 to 5·69; P < 0·001). Conclusion Global differences existed in the proportion of patients receiving end stomas after left-sided colorectal resection based on income, which went beyond case mix alone

Production of pregelatinised maize starch compared with maize starch as ingredient in pharmaceutical solid dose forms

Pregelatinised maize starch was prepared from evaporating to dryness 8%w/v of maize starch mucilage and pulverising it. Its physicochemical properties were compared with maize starch powder. Its higher and tapped densities resulted in lower Carr's index. Its higher particle flow rate lower angle of reponse could render it a better candidate in capsule filling and tablet compression. The later properties could allow more uniform dose distribution by weight and lower power consumption for compression. Its higher intraparticulate porosity and more amorphous disruption by the gelatinisation could cause dose form faster disentegration and therefore enhanced faster dissolution for faster drug bioavailability. Key words: Pregelatinised starch; Maize starch; Physicochemical properties, Comparative pharmaceutical excipient. Nig. J. Pharm. Res. 3(1) 2004: 66-7